Navigation Links
Reuters Highlights NutraPharma Financial Giant Predicts NutraPharma (OTCBB: NPHC) Shares Likely to Outperform the Market
Date:9/8/2009

Thomson Reuters, one of the world’s largest stock market analytics firms which is also ranked as one of Britain’s most respected companies, has singled out NutraPharma shares as likely to outperform the market based on its “proprietary quantitative model”.

(Vocus) September 8, 2009 -- Thomson Reuters, one of the world’s largest stock market analytics firms which is also ranked as one of Britain’s most respected companies, has singled out NutraPharma shares as likely to outperform the market based on its “proprietary quantitative model”. Reuter’s description of what this "technical" ranking means is quoted below.

“We cannot guarantee that each stock will perform in accordance with its rank. But we do believe that over the long term, stocks rated Outperform (30% of all stocks we rate) will, in the aggregate, outperform stocks rated Neutral (40% of all stocks we rate), and that stocks rated Neutral will, in the aggregate, outperform stocks rated Underperform (30%). All analysis is based on publicly available company financials, fundamental ratios, relative rankings of financial data and ratios, and observed equity prices”

See the report here: http://www.undiscoveredequities.com/nphc_reuters.pdf

Undiscovered Equities is currently offering a complimentary trial subscription.

To view our newsletter on a complimentary trial basis and take advantage of our other services go to www.undiscoveredequities.com and join our email list on our home page.

# # #

Read the full story at http://www.prweb.com/releases/nphc/reuters/prweb2837384.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Transcept Pharmaceuticals to Present at the BioCentury Thomson Reuters Newsmakers in the Biotech Industry Conference on September 16, 2009
2. Thomson Reuters Joins the InChI Trust
3. Thomson Reuters Announces 2009 Edition of the CMR International Pharmaceutical R&D Factbook
4. Thomson Reuters Partners With Sagient Research
5. Brazils Scientific Research On The Rise, Thomson Reuters Study Finds
6. Thomson Reuters Makes Disease Briefing on Influenza Covering H1N1 (Swine Flu) Publicly Available
7. Thomson Reuters Examines Highly Cited Research in Bioterrorism
8. Thomson Reuters Commemorates World IP Week with Series of Strategic Intellectual Property Seminars Across the U.S.
9. APS Healthcare and Thomson Reuters to Manage New York States Medicaid Clinical Best Practices Review Program
10. Thomson Reuters Names Hottest Researchers and Papers of 2007-2008
11. Despite Decline in Share of Global Output, U.S. Science Impact Still Strong, Says Thomson Reuters
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Reuters Highlights NutraPharma Financial Giant Predicts NutraPharma (OTCBB: NPHC) Shares Likely to Outperform the Market
(Date:10/11/2017)... ... October 11, 2017 , ... The ... endogenous context, enabling overexpression experiments and avoiding the use of exogenous expression plasmids. ... is transformative for performing systematic gain-of-function studies. , This complement to loss-of-function ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/10/2017)... Angeles, CA (PRWEB) , ... ... ... Inc., a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, ... uses of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in ...
(Date:10/10/2017)... BARBARA, CALIFORNIA (PRWEB) , ... October 10, 2017 ... ... management, technological innovation and business process optimization firm for the life sciences and ... BoxWorks conference in San Francisco. , The presentation, “Automating GxP Validation ...
Breaking Biology Technology:
(Date:8/15/2017)... , Aug. 15 2017   ivWatch LLC , a medical ... (IV) therapy, today announced receipt of its ISO 13485 Certification, the ... the International Organization for Standardization (ISO®). ... ivWatch Model 400 Continuous Monitoring device for the early detection ... "This is an important ...
(Date:6/23/2017)... and ITHACA, N.Y. , June ... Cornell University, a leader in dairy research, today announced ... designed to help reduce the chances that the global ... onset of this dairy project, Cornell University has become ... Sequencing the Food Supply Chain, a food safety initiative ...
(Date:5/16/2017)...  Veratad Technologies, LLC ( www.veratad.com ), an innovative ... verification solutions, announced today they will participate as a ... thru May 17, 2017, in Washington D.C.,s ... Identity impacts the lives of billions ... evolving digital world, defining identity is critical to nearly ...
Breaking Biology News(10 mins):